M. Hamidou
Impact in
- Hematology top 1%
- Platelet Disorders and Treatments
- Rheumatology top 0.5%
- Eosinophilic Disorders and Syndromes
- Systemic Lupus Erythematosus Research
Papers in
- Hematology 52
- Platelet Disorders and Treatments 19
- Autoimmune and Inflammatory Disorders Research 15
- Rheumatology 67
- Systemic Lupus Erythematosus Research 18
- Otitis Media and Relapsing Polychondritis 14
- Co-authors
- A. NéelC. AgardA. MasseauPhilippe MoreauJean‐Yves GrolleauÉ. HachullaBéatrice CharreauB. Hervier
- Journals
- Blood (12 papers)Lara D. Veeken (8 papers)Seminars in Arthritis and Rheumatism (7 papers)Annals of the Rheumatic Diseases (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
M. Hamidou
213 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 100
- Hematology 1.0k
- Rheumatology 1.3k
- Genetics 806
- Immunology 1.2k
- Nephrology 360
Countries citing papers authored by M. Hamidou
This map shows the geographic impact of M. Hamidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hamidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hamidou more than expected).
Fields of papers citing papers by M. Hamidou
This network shows the impact of papers produced by M. Hamidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hamidou. The network helps show where M. Hamidou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Hamidou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 33 | |
| 5 | 2019 | 14 | |
| 6 | 2019 | 6 | |
| 7 | Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. | 2017 | 18 |
| 8 | 2017 | 1 | |
| 9 | 2016 | 45 | |
| 10 | 2016 | 36 | |
| 11 | 2014 | 2 | |
| 12 | 2010 | 2 | |
| 13 | 2009 | 0 | |
| 14 | 2008 | 34 | |
| 15 | 2005 | 7 | |
| 16 | 2004 | 3 | |
| 17 | Les passages non justifiés au service d'accueil urgences : Proposition d'une offre de soins différenciée. | 2004 | 7 |
| 18 | 2002 | 3 | |
| 19 | Spectre des proliférations LGL et nouveaux concepts physiopathogéniques | 1999 | 3 |
| 20 | Faut-il traiter les anémies hémolytiques auto-immunes comme il y a 30 ans ? | 1998 | 2 |
About M. Hamidou
M. Hamidou is a scholar working on Hematology, Rheumatology, Genetics, Microbiology and Pulmonary and Respiratory Medicine, having authored 229 papers that have together received 4.4k indexed citations. Recurring topics across this work include Vasculitis and related conditions (54 papers), Sarcoidosis and Beryllium Toxicity Research (21 papers), Platelet Disorders and Treatments (19 papers), Systemic Lupus Erythematosus Research (18 papers), Chronic Lymphocytic Leukemia Research (15 papers), Autoimmune and Inflammatory Disorders Research (15 papers), Renal Diseases and Glomerulopathies (15 papers) and Otitis Media and Relapsing Polychondritis (14 papers). The work is most often cited by research in Hematology (1.0k citations), Rheumatology (1.3k citations), Genetics (806 citations), Immunology (1.2k citations) and Nephrology (360 citations). M. Hamidou has collaborated with scholars based in France, Canada and United States. Frequent co-authors include A. Néel, C. Agard, A. Masseau, Philippe Moreau, Jean‐Yves Grolleau, É. Hachulla, Béatrice Charreau, B. Hervier, Stéphanie Coupel and Václav Hořejšı́. Their work appears in journals such as Blood, Lara D. Veeken, Seminars in Arthritis and Rheumatism, Annals of the Rheumatic Diseases and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.